Search

Your search keyword '"Cameron, J.L."' showing total 189 results

Search Constraints

Start Over You searched for: Author "Cameron, J.L." Remove constraint Author: "Cameron, J.L." Search Limiters Peer Reviewed Remove constraint Search Limiters: Peer Reviewed Publication Year Range Last 50 years Remove constraint Publication Year Range: Last 50 years
189 results on '"Cameron, J.L."'

Search Results

2. Grading Pancreatic Neuroendocrine Tumors via Endoscopic Ultrasound-Guided Fine Needle Aspiration: A Multi-Institutional Study

3. Accuracy of grading pancreatic neuroendocrine tumors on endoscopic ultrasound-guided fine needle aspiration: a multi-institutional study

5. Impact of liver disease and parenchymal changes on patterns of liver recurrence in patients with resected PDAC: a new insight into the biological behavior of this lethal disease

8. Presence Of Transitional Circulating Tumor Cells Following Resection Is Associated With Worse Survival In Patients With Delayed Initiation Of Adjuvant Therapy

9. Systemic therapy in pancreatic ductal adenocarcinoma: Does drug selection, sequence, and duration impact survival

13. Circulating tumor cells dynamics in pancreatic adenocarcinoma correlate with disease status: Results of the prospective cluster study

18. A genetic risk nomogram for patients with colorectal liver metastases: the central role of BRAF mutational status in stratifying outcomes

20. Surgical outcomes in patients with resected insulinoma

22. Recurrent or metachronous adenocarcinoma of the pancreatic remnant: long-term survival after completion pancreatectomy

24. Neoadjuvant Stereotactic Body Radiation Therapy for Borderline Resectable and Locally Advanced Pancreatic Cancer: Prognostic Factors for Local Recurrence and Survival

25. Predictive Factors of Pathologic Response in Patients With Localized Pancreatic Cancer Treated With Induction Chemotherapy and Stereotactic Body Radiation Therapy

28. Dosimetric Correlations with Toxicity in the First Experience Validating Adjuvant Fractionated Stereotactic Body Radiation Therapy for Resectable Pancreatic Cancer

29. Dosimetric Parameters Correlate With Node Negative Resection in Borderline and Initially Unresectable Pancreatic Adenocarcinoma Patients Treated With Stereotactic Body Radiation Therapy Followed by Surgical Resection

30. Pathologic Outcomes in Borderline Resectable and Locally Advanced Pancreatic Cancer Patients Receiving Neoadjuvant Stereotactic Body Radiation Therapy

31. Preliminary Results of a Pilot Study Evaluating An Allogeneic GM-CSF Pancreatic Tumor Cell Vaccine (GVAX) and Cytoxan (Cy) With Stereotactic Body Radiation Therapy (SBRT) and Folfirinox (FFX) in Patients With Resected Pancreatic Adenocarcinoma

38. 140 Portal/Superior Mesenteric Vein Resections During Pancreaticoduodenectomy: Evolution of Technique and Lessons Learned

49. QS322. Is it Safe to Observe Asymptomatic Branch Duct or Mixed-Type Intraductal Papillary Mucinous Neoplasms (IPMN) Less Than 3CM and Without a Solid Component?: The Pathological Findings of 16 Patients Who Underwent Pancreatectomy for This Condition

Catalog

Books, media, physical & digital resources